Brookfield’s $4.4bn Healthscope takeover gets final approval
Healthscope will exit the ASX after the Federal Court approved Brookfield’s $4.4bn buyout.
The Federal Court has given final approval to Brookfield Asset Management’s $4.4 billion buyout of private hospital operator Healthscope.
The court’s orders are expected to be lodged with the Australian Securities and Investments Commission later on Friday, making it legally effective. Healthscope (HSO) shares will also be suspended from trading from Friday, with its place in the ASX200 replaced by Cooper Energy.
Healthscope operates 43 private hospitals in Australia, as well as 24 pathology laboratories in New Zealand.
This is the second time the healthcare company has been taken private. Private equity firms TPG Capital and The Carlyle Group bought Healthscope in 2010 and then relisted it in 2014.
AAP
The $34bn chemist merger sealed over lasagne
The Chemist Warehouse founders were back in suburban Melbourne to vote in its huge merger with ASX-listed Sigma. The celebrations were a typically low-key setting for some of Australia’s richest entrepreneurs.
How Chemist Warehouse passed the pub test
The founders of the retail juggernaut have got bigger by sticking close to their market. Now Chemist Warehouse faces the ultimate test.